C

    Cardlytics Inc (CDLX)

    Official site

    COMMUNICATION SERVICES • ADVERTISING AGENCIES • NASDAQ

    $4.03
    +0.01 (+0.25%)

    Market Cap: $23.67M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    77%(27/35)
    Avg Surprise
    +34.51%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-1.04
    Range$-1.25 - $-0.83
    2 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-0.90+13.5%
    60d ago$-0.87+16.7%
    30d ago$-1.10-5.8%
    7d ago$-1.10-5.8%
    Current$-1.04
    Revenue Consensus
    $37M
    Range$34M - $39M
    3 analysts
    Dec 31, 2026
    EPS Consensus$0.33
    Range$-0.66 - $1.31
    2 analysts
    Revenue Consensus
    $37M
    Range$35M - $40M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.33---
    Sep 26EST
    		-$-1.04---
    Jun 26
    		$-1.50$-1.35-11.11%Miss-15.4%
    Mar 26
    		$-1.10$-2.13+48.36%Beat+47.6%
    Dec 25
    		$0.03N/A+110.84%Beat+109.7%
    Sep 25
    		$-1.36$-0.33-312.12%Miss+9.3%
    Jun 25
    		$-1.30$-1.62+19.75%Beat+13.3%
    Mar 25
    		$-2.10$-2.67+21.35%Beat-133.3%
    Dec 24
    		$-0.31$-0.52+40.38%Beat-321.4%
    Sep 24
    		$-1.50$-2.67+43.82%Beat-1600.0%
    Jun 24
    		$-1.50$-1.97+23.86%Beat+37.5%
    Mar 24
    		$-0.90$-1.10+18.18%Beat+64.0%
    Dec 23
    		$0.14$0.12+16.67%Beat+148.3%
    Sep 23
    		$0.10$-0.10+200.00%Beat+102.0%
    Jun 23
    		$-2.40$-4.31+44.32%Beat+63.1%
    Mar 23
    		$-2.50$-4.43+43.57%Beat+34.2%
    Dec 22
    		$-0.29$-0.46+36.96%Beat-93.3%
    Sep 22
    		$-5.02$-4.49-11.80%Miss-52.1%
    Jun 22
    		$-6.50$-5.00-30.00%Miss-66.7%
    Mar 22
    		$-3.80$-5.54+31.41%Beat-11.8%
    Dec 21
    		$-0.15N/A+64.29%Beat-200.0%
    Sep 21
    		$-3.30$-4.93+33.06%Beat-106.2%
    Jun 21
    		$-3.90$-3.12-25.00%Miss-3.2%
    Mar 21
    		$-3.40$-3.09-10.03%Miss-30.8%
    Dec 20
    		$-0.05$-0.03-66.67%Miss-127.8%
    Sep 20
    		$-1.60$-2.79+42.65%Beat-633.3%
    Jun 20
    		$-3.78$-4.74+20.25%Beat-215.0%
    Mar 20
    		$-2.60$-2.22-17.12%Miss-13.0%
    Dec 19
    		$0.18$0.04+350.00%Beat+400.0%
    Sep 19
    		$0.30N/A+120.69%Beat+120.0%
    Jun 19
    		$-1.20$-2.26+46.90%Beat+42.9%
    Mar 19
    		$-2.30$-3.65+36.99%Beat+34.3%
    Dec 18
    		$-0.06N/A+64.71%Beat+66.7%
    Sep 18
    		$-1.50N/A+63.33%Beat-400.0%
    Jun 18
    		$-2.10$-3.94+46.70%Beat-650.0%
    Mar 18
    		$-3.50$-5.37+34.82%Beat-438.5%
    Dec 17
    		$-0.18N/A+67.86%Beat-
    Sep 17
    		$-0.30$0.00N/AMiss-
    Jun 17
    		$-0.28$0.00N/AMiss-
    Mar 17
    		$-0.65$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-1.03EV/EBITDA-7.69x
    Price/FCF-2.13xFCF Yield-46.96%
    Profitability
    Profit Margin-52.80%Operating Margin-14.70%
    ROE-513.00%ROIC-43.17%
    Financial Health
    Debt/Equity-11.52xInterest CoverageN/A
    Current Ratio1.62xQuick Ratio1.62x
    Trading Statistics
    Beta0.67Avg Volume46.11K
    52-Week High$32.8052-Week Low$3.49

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.17
    SMA 20$4.07
    SMA 50$4.20
    SMA 200$8.16
    EMA 10$4.11
    EMA 20$4.11
    EMA 50$4.51
    EMA 200$8.31

    MACD

    Line: -0.03Signal: -0.04Hist: 0.01

    ADX

    ADX: 20.4+DI: 19.1-DI: 14.0

    Aroon & PSAR

    Aroon Up68.0
    Aroon Down36.0
    PSAR$4.97

    Bollinger Bands

    Upper Band$4.51
    Lower Band$3.62
    %B Position2193%(Upper)
    Band Width0.46

    RSI (14-Day)

    Neutral
    45.7

    Momentum Oscillators

    Stoch %K28.5
    Stoch %D36.2
    Williams %R-76.3
    ROC (10d)-0.5%
    Momentum-0.02
    CCI (20d)-31.3
    MFI (14d)50.6

    Volatility Measures

    ATR (14d)$0.37(9.2%)
    StdDev (20d)0.22
    Hist Vol72.0%(High)

    Volume Flow

    VWAP$4.00
    OBV73.3M
    AD Line76.9B
    CMF (20d)-0.073

    Volume Metrics

    Avg Vol (20d)46.7K
    Vol Ratio1.4x
    VWMA (20d)$4.03

    Pivot Points

    R3$4.23
    R2$4.18
    R1$4.10
    Pivot Point$4.06
    S1$3.97
    S2$3.93
    S3$3.85

    Advanced Oscillators

    TSI-2.94
    Ultimate Osc44.7
    KST37.75

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$36.88M$34.32M$56.09M$52.03M$58.04M$56.44M$74.00M$67.06M$69.64M$67.61M$89.17M$79.00M
    Cost of Revenue$0$0$30.20M$0$0$0$41.26M$0$0$0$49.68M$0
    Gross Profit$36.88M$34.32M$56.09M$52.03M$58.04M$56.44M$74.00M$67.06M$69.64M$67.61M$89.17M$79.00M
    Operating Expenses$42.32M$42.59M$62.19M$120.89M$67.61M$67.55M$82.31M$215.60M$85.45M$90.43M$192.09M$99.66M
    R&D$5.54M$6.43M$7.96M$8.80M$9.87M$10.28M$9.89M$13.19M$13.47M$13.05M$12.51M$12.43M
    SG&A$7.86M$8.28M$9.73M$10.85M$12.24M$12.94M$13.77M$12.08M$16.15M$14.48M$13.90M$15.56M
    Operating Income$-5,441,000$-8,274,000$-6,094,000$-68,854,000$-9,569,000$-11,115,000$-8,315,000$-148,546,000$-15,812,000$-22,826,000$-102,922,000$-20,652,000
    Interest Income$-3,383,000$-3,818,000$0$-2,007,000$-1,943,000$-1,830,000$0$-1,479,000$-1,561,000$0$0$0
    Interest Expense$3.22M$5.52M$-1,830,000$0$0$0$-819,000$0$-13,017,000$819,000$-1,497,000$915,000
    Income Before Tax$-8,659,000$-13,798,000$-8,250,000$-72,673,000$-6,063,000$-10,318,000$-15,590,000$-145,182,000$-4,257,000$-24,275,000$-100,836,000$-23,966,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-14,876,000$-4,480,000$-8,250,000$-72,673,000$-9,283,000$-13,282,000$-15,590,000$-145,182,000$-4,257,000$-24,275,000$-100,836,000$-23,966,000
    EBITDA$-580,000$-4,910,000$798,000$-63,288,000$3.20M$-1,160,000$-6,998,000$-135,793,000$-8,256,000$-16,212,000$-92,640,000$-16,044,000
    EBIT$-5,276,000$-9,980,000$-6,111,000$-70,666,000$-4,120,000$-8,488,000$-13,896,000$-143,703,000$-15,713,000$-23,456,000$-99,997,000$-23,051,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CDLX

    News

    Cardlytics (NASDAQ: CDLX) revises earlier insider trade filing

    Cardlytics (NASDAQ: CDLX) has filed a Form 4/A to amend an earlier insider trade filing, correcting the number of restricted stock units (RSUs) awarded to director Francis Jonathan Edward. The amendment clarifies that the director was awarded RSUs representing 2,200 shares, adjusted for a 1-for-10 reverse stock split effective June 5, 2026. These RSUs are set to vest on the one-year anniversary of the grant date, provided the director remains with the company.

    Stock Titan•8/25/26•
    Neutral

    Cardlytics CEO Amit Gupta disposes of 13,461 common shares for $53,974

    Cardlytics CEO Amit Gupta sold 13,461 shares of common stock for a total of $53,974 on August 17-18, 2026. The sales, at weighted-average prices of $3.97 and $4.03, reduced his direct stake to 125,389 shares. Prior to these sales, Gupta had received 25,000 shares from restricted stock unit vesting on August 16.

    Bitget•8/18/26•
    Somewhat-Bearish

    Cardlytics (CDLX) insider plans sale including tax-cover shares

    Cardlytics, Inc. (CDLX) insider Amit Gupta has filed a Form 144 notice indicating a planned sale of up to 6,676 shares of common stock. These shares are related to restricted stock vesting and include an amount to cover tax obligations from a vested equity award distribution. The filing also details previous sales by Amit Gupta in July and August 2026.

    Stock Titan•8/18/26•
    Neutral

    Cardlytics (CDLX) CEO sells shares outside 10b5-1 plan

    Cardlytics, Inc. CEO Amit Gupta reported the sale of 13,461 shares of common stock on August 17-18, 2026, at weighted average prices of $3.966 and $4.031, respectively. These sales followed the vesting of 25,000 Restricted Stock Units (RSUs) on August 16, 2026, and were explicitly not conducted under a Rule 10b5-1 trading plan. The RSUs originated from two 50,000-share awards granted in 2024 and 2025, vesting in installments over 24 months.

    Stock Titan•8/18/26•
    Somewhat-Bearish

    Cardlytics (NASDAQ: CDLX) insider plans to sell up to 6,785 shares

    Cardlytics (NASDAQ: CDLX) insider Amit Gupta has filed a Form 144, indicating an intention to sell up to 6,785 shares of common stock. These shares are related to restricted stock that vested on August 14, 2026, and the sale is anticipated to occur on or after August 17, 2026, through Fidelity Brokerage Services LLC. The filing also details two prior sales of CDLX common stock by Gupta in early July 2026.

    Stock Titan•8/17/26•
    Neutral

    Frequently Asked Questions About CDLX

    Does CDLX pay dividends?
    Cardlytics Inc (CDLX) does not currently pay a regular dividend.
    What is CDLX's market cap?
    Cardlytics Inc (CDLX) has a market capitalization of $23.67M with a current stock price of $4.03.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In